NFE2L2 and neoplasm: Few more studies have suggested that other proteins, such as p21 or p62, also restrict the Keap1–Nrf2 interaction and induce Nrf2-associated drug resistance in tumor cells (Chen et al., 2009; Lau et al., 2010).